Search Results

Injectsense Inc., a sensor-enabled digital health company, announced that the ethics committee at the Centro de la Vision Clinic in Santiago, Chile, has approved a 20-patient study that will confirm safety and effectiveness of the company’s ultra-miniature wireless pressure sensor, designed to continuously measure intra-ocular pressure (IOP) for glaucoma.

The French pharma is getting Black Diamond’s de-prioritized molecule for non-small cell lung cancers with specific mutations whose development had been paused to save money.

Echosens announced the appointment of Victor de Lédinghen, MD PhD, as the company’s new Chief Medical Officer.

MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the U.S. Food and Drug Administration’s (FDA) De Novo granting for Onkos Surgical’s antibacterial coating for tumor and revision orthopedic implants.

MedGenome, a global partner for comprehensive multiomics solutions, in collaboration with PacBio, is pleased to announce Dr. Lauren Esposito of the California Academy of Sciences as the recipient of the ‘2024 de novo genome assembly and annotation grant’.